However, there was no significant correlation between BIM deletion polymorphism and OS in EGFR-mutated NSCLC (univariate analysis: Ph = 0.057, HR = 1.361, 95%CI = 0.559–3.315) and HCC (univariate analysis: HR = 1.170, 95%CI = 0.740–1.850; multivariate analysis: HR = 0.668, 95%CI = 0.300–1.500), respectively (Table 3 and Fig. 3). This evidence concerns the gene BCL2L11 and hepatocellular carcinoma.